![](https://stockhead.com.au/wp-content/uploads/2025/02/GettyImages-2198618478-1200x675-1.jpg)
Biocurious: Hut Hut Hut! The growing list of ASX biotechs waiting for the FDA to call the start of play
Having lodged their paperwork, companies including EBR Systems, Artyra and Orthocell await crucial FDA approval The agency has improved its communications with applicants, which avoids nasty surprises Applicants are doing the commercial groundwork ahead of …